Results 21 to 30 of about 229,775 (251)

Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18F-FDG PET/CT in patients with localized primary gastrointestinal stromal tumors

Cancer & Metabolism, 2021
Background This study aimed to evaluate the prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with localized primary gastrointestinal stromal tumors (GISTs) and to ...
Sang Hyun Hwang, Minkyu Jung, Yong Hyu Jeong, KwanHyeong Jo, Soyoung Kim, Jiyoung Wang, Arthur Cho   +6 more
doaj   +1 more source

Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume

Radiation Oncology, 2020
Background We evaluated whether pre- and mid-treatment metabolic tumor volume (MTV) predicts per lesion local recurrence (LR) in patients treated with definitive radiation therapy (RT, dose≥60 Gy) for locally advanced non-small cell lung cancer (NSCLC ...
Michael S. Binkley, Julie L. Koenig, Mehr Kashyap, Michael Xiang, Yufei Liu, Quaovi Sodji, Peter G. Maxim, Maximilian Diehn, Billy W. Loo, Michael F. Gensheimer   +9 more
doaj   +1 more source

Prognostic value of F-FDG PET/CT metabolic parameters in small cell lung cancer

Journal of International Medical Research, 2020
Objective To compare the prognostic values of metabolic parameters from pretreatment PET/CT between limited disease (LD) and extensive disease (ED) small cell lung cancer (SCLC) patients. Methods Data on 118 newly diagnosed SCLC patients (50 LD and 68 ED)
Eun Kyoung Choi, Minjae Park, Jooyeon Jamie Im, Yong-An Chung, Jin Kyoung Oh   +4 more
doaj   +1 more source

Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study

BioMedical Engineering OnLine, 2023
Background Tumor heterogeneity is recognized as a predictor of treatment response and patient outcome. Quantification of tumor heterogeneity across all scales may therefore provide critical insight that ultimately improves cancer management.
Hanna Jönsson, Håkan Ahlström, Joel Kullberg   +2 more
doaj   +1 more source

Correlation of Segmented Metabolic Tumor Volume with Outcome - Response [PDF]

Clinical Cancer Research, 2010
We appreciate Dr. Troost et al.'s interest and thoughtful comments on our article ([1][1]). Our study was intended to investigate the relationship between the metabolic tumor volumes (MTV) measured on 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) and short-term outcome in ...
Man Ki Chung, Chung-Hwan Baek, Joon Young Choi   +2 more
openaire   +1 more source

A Retrospective Analysis of the Most Common Bone Metastases of Various Malignant Tumors with Cross-sectional Imaging and 18-FDG-PET/CT Data

Bagcilar Medical Bulletin, 2022
Objective:To evaluate bone metastases quantitatively and qualitatively with cross-sectional imaging and fluor-18 fluorodeoxyglucose-positron emission tomography (18-FDG-PET) computed tomograph (CT) data.Method:To obtain study data, the archive of the ...
Mehmet Öncü, Deniz Özel
doaj   +1 more source

Measurement of metabolic tumor volume: static versus dynamic FDG scans [PDF]

EJNMMI Research, 2011
Abstract Background Metabolic tumor volume assessment using positron-emission tomography [PET] may be of interest for both target volume definition in radiotherapy and monitoring response to therapy. It has been reported, however, that metabolic volumes derived from images of metabolic rate of glucose (generated using
Cheebsumon, P., van Velden, F.H.P., Yaqub, M.M., Hoekstra, C.J., Velasquez, L.M., Hayes, W., Hoekstra, O.S., Lammertsma, A.A., Boellaard, R.   +8 more
openaire   +2 more sources

Prognostic Value of ¹⁸F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Node-Negative Stage II Esophageal Squamous Cell Carcinoma

Metabolites, 2021
Esophageal squamous cell carcinoma (ESCC) is a major cancer prevalent in Asian males. Pretreatment tumor burden can be prognostic for ESCC. We studied the prognostic value of metabolic parameters of 2-deoxy-2-[18F] fluoro-D-glucose positron emission ...
Daniel Hueng-Yuan Shen, Hung-Pin Chan, Fu-Ren Tsai, Chin Hu, Allan Yi-Nan Chen, Hung-Yen Chan, Che-Hsin Lee, Kuo-Pin Chuang, Ming-Hui Yang, Yu-Chang Tyan   +9 more
doaj   +1 more source

Metabolic Tumor Volume: We Still Need a Platinum-Standard Metric [PDF]

Journal of Nuclear Medicine, 2016
In this issue of The Journal of Nuclear Medicine, Cottereau et al. ([1][1]) retrospectively evaluate data compiled from a cohort of 106 peripheral T cell lymphoma patients, 50% of whom were previously enrolled in Lymphoma Study Association (LYSA) studies coordinated by 5 French and Belgian ...
Andrea, Gallamini, Lale, Kostakoglu
openaire   +2 more sources

Reproducibility of Standardized Uptake Values Including Volume Metrics Between TOF-PET-MR and TOF-PET-CT

Frontiers in Medicine, 2022
PurposeTo investigate the reproducibility of tracer uptake measurements, including volume metrics, such as metabolic tumor volume (MTV) and tumor lesion glycolysis (TLG) obtained by TOF-PET-CT and TOF-PET-MR.Materials and MethodsEighty consecutive ...
Aruki Tanaka, Tetsuro Sekine, Tetsuro Sekine, Tetsuro Sekine, Tetsuro Sekine, Edwin E. G. W. ter Voert, Edwin E. G. W. ter Voert, Konstantinos G. Zeimpekis, Konstantinos G. Zeimpekis, Konstantinos G. Zeimpekis, Gaspar Delso, Felipe de Galiza Barbosa, Felipe de Galiza Barbosa, Geoffrey Warnock, Geoffrey Warnock, Geoffrey Warnock, Shin-ichiro Kumita, Patrick Veit Haibach, Patrick Veit Haibach, Patrick Veit Haibach, Patrick Veit Haibach, Martin Huellner, Martin Huellner   +22 more
doaj   +1 more source